Home > Result Summaries: Compounds > Dutasteride > Result Summary for ARI40007

Result Summary for ARI40007

Result Summary
Protocol ID: ARI40007
Clinical Study ID: ARI40007
Official Title: A Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study Investigating the Effects of Either 4 or 6 Weeks Dutasteride 0.5mg Daily on Peri-Operative Bleeding Following Transurethral Resection of the Prostate (TURP) in Subjects with Benign Prostatic Hyperplasia (BPH).
Phase: Phase 3
Study Indications or Diseases:
  • Prostatic Hyperplasia
Generic Name: dutasteride
Trade/Product Name: Duagen,Zytefor,Avolve,Avodart,Avidart,Zyfetor
Approved Drug Label: http://www.gsk.com/products/prescription-medicines/index.htm
Results Summary: Click here to download result summary. Click here to download result summary.
Citations: